William Blair & Company’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-3,985
| Closed | -$219K | – | 1725 |
|
|
2019
Q3 | $219K | Sell |
3,985
-2,108
| -35% | -$116K | ﹤0.01% | 1233 |
|
|
2019
Q2 | $247K | Buy |
+6,093
| New | +$247K | ﹤0.01% | 1226 |
|
|
2019
Q1 | – | Sell |
-7,154
| Closed | -$240K | – | 1701 |
|
|
2018
Q4 | $240K | Sell |
7,154
-191
| -3% | -$6.41K | ﹤0.01% | 1175 |
|
|
2018
Q3 | $310K | Buy |
7,345
+168
| +2% | +$7.09K | ﹤0.01% | 1129 |
|
|
2018
Q2 | $230K | Hold |
7,177
| – | – | ﹤0.01% | 1220 |
|
|
2018
Q1 | $357K | Buy |
7,177
+1,157
| +19% | +$57.6K | ﹤0.01% | 1026 |
|
|
2017
Q4 | $325K | Sell |
6,020
-1,615
| -21% | -$87.2K | ﹤0.01% | 1101 |
|
|
2017
Q3 | $443K | Sell |
7,635
-656
| -8% | -$38.1K | ﹤0.01% | 968 |
|
|
2017
Q2 | $409K | Buy |
8,291
+953
| +13% | +$47K | ﹤0.01% | 1034 |
|
|
2017
Q1 | $319K | Buy |
+7,338
| New | +$319K | ﹤0.01% | 1032 |
|